Today we will talk about the investment fund Perceptive Advisors, namely, about the latest purchases of shares of the companies of this fund.
Fund name: Perceptive Advisors
Founder and head of the fund: Joseph Edelman
Portfolio value:~ $951,682,000
Foundation date: 1999 year
This foundation drew attention to itself quite by accident., namely, the growth of shares of AmicusTherapeutics, Inc. (NASDAQ:FOLD). The fact, what for the last 2 of the day, the company's shares rose from $3 to $4.25, for a cheap promotion (penny stock) this is a very decent growth.
30 June 2014 the company issued a press release:http://files.shareholder.com/downloads/AMTX/3295185935x0x765801/eae79482-0ea9-4ba6-958b-bc186ff2a7db/FOLD_News_2014_6_30_General.pdf
Where the updated and final analysis of the plan is presented 3 Phases of Fabry Disease Treatment. Fabry disease - a rare hereditary pathology, одна из 40 currently known lysosomal storage diseases (diseases with impaired lipid metabolism), along with Gaucher disease, mucopolysaccharidosis and others. We will not go into details..
It also became known that the Perceptive Advisors fund 30 June bought shares of this company at a price $3,5 per share in the amount $14,000,000, agree in such a short time very good %.
Let's analyze fund purchases from 2012 of the year.
From October 2012 G. fund started buying shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:SICKNESS) at ~ $ 21 per share.
IN 2013 year in January and February, the fund bought shares at prices $26.07 — $27.79.
And in September 2013 of the year the fund sold 750 000 shares worth $66,900,000 at a price already $89.2 per share. In less than a year, the fund earned on AEGR shares Order 300%.
The fund also began to buy shares of AcelRx Pharmaceuticals Inc in small amounts.. (NASDAQ: ACRX) since July 2013 G. at a price in $11,6 per share. В октябре цена опустилась ниже 7$ and the fund also bought shares at $6,9, $6,8, $6,5.
The share price several times approached $13 and defended there, in 2014 G. the price per share was the highest $13,6. At the moment, the shares are $10.8 and are on their way to the coveted figure $13 and if everything goes well and the milestone is crossed and the way up is open.
We have considered 3 last purchases of shares of companies by an investment fund. Examining the fund's reporting on the acquisition of company shares, можно неплохо заработать. Следите за сделками инсайдеров, look for an entry point and it will bring you good %.
